Cours Satsuma Pharmaceuticals, Inc.
Actions
STSA
US80405P1075
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/06/23 |
Mic Iwashima
COO | Chief Operating Officer | 46 | 01/01/17 |
Chief Tech/Sci/R&D Officer | 63 | 01/07/17 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/06/23 |
Director/Board Member | 64 | 08/06/23 | |
Ken Takanashi
BRD | Director/Board Member | 59 | 01/06/16 |
Varia. 1 janv. | Capi. | |
---|---|---|
+2,56 % | 108 Md | |
+10,02 % | 104 Md | |
+7,45 % | 23,66 Md | |
-11,91 % | 22,1 Md | |
-3,29 % | 19,71 Md | |
-35,98 % | 18,2 Md | |
-14,02 % | 16,19 Md | |
+4,61 % | 13,72 Md | |
+35,05 % | 12,22 Md |